Instanyl® Non-Interventional Study

Mise à jour : Il y a 4 ans
Référence : NCT01045603

Femme et Homme

Extrait

The aim of this study is to describe the use of Instanyl® (Intranasal fentanyl spray) in the treatment of breakthrough pain (BTP) in cancer patients by success of dose titration and distribution of dose strength. Data will be collected at three different time points over a 3 month period.


Critère d'inclusion

  • Breakthrough Cancer Pain


Liens